Abstract
The effective identification, selection, and implementation of small molecules for the interrogation of biological systems require an intricate understanding of the chemical principles underlying their cellular activities. While much has been published regarding the use of screening techniques in forward chemical genetics platforms and on small-molecule target identification, less emphasis has been placed on detailed strategies for evaluating, selecting, and optimizing screening hits. This chapter provides practical tools for identifying and developing promising screening hit compounds into effective tools for biological discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bucci M, Goodman C, Sheppard TL (2010) A decade of chemical biology. Nat Chem Biol 6:847–854
Alaimo PJ, Shogren-Knaak MA, Shokat KM (2001) Chemical genetic approaches for the elucidation of signaling pathways. Curr Opin Chem Biol 5:360–367
Frearson JA, Collie IT (2009) HTS and hit finding in academia–from chemical genomics to drug discovery. Drug Discov Today 14:1150–1158
Hasson SA, Inglese J (2013) Innovation in academic chemical screening: filling the gaps in chemical biology. Curr Opin Chem Biol 17:329–338
Huryn DM (2013) Drug discovery in an academic setting: playing to the strengths. ACS Med Chem Lett 4:313–315
Garcia-Serna R, Mestres J (2011) Chemical probes for biological systems. Drug Discov Today 16:99–106
Macarron R et al (2011) Impact of high-throughput screening in biomedical research. Nat Rev Drug Discov 10:188–195
Castoreno AB, Eggert US (2011) Small molecule probes of cellular pathways and networks. ACS Chem Biol 6:86–94
Prior M et al (2014) Back to the future with phenotypic screening. ACS Chem Neurosci 5:503–513
Lee JA, Berg EL (2013) Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. J Biomol Screen 18:1143–1155
Eggert US (2013) The why and how of phenotypic small-molecule screens. Nat Chem Biol 9:206–209
Tamplin OJ et al (2012) Small molecule screening in zebrafish: swimming in potential drug therapies. Wiley Interdiscip Rev Dev Biol 1:459–468
Gonzalez C (2013) Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer 13:172–183
O’Connor CJ, Laraia L, Spring DR (2011) Chemical genetics. Chem Soc Rev 40:4332–4345
Spring DR (2005) Chemical genetics to chemical genomics: small molecules offer big insights. Chem Soc Rev 34:472–482
Workman P, Collins I (2010) Probing the probes: fitness factors for small molecule tools. Chem Biol 17:561–577
Lipinski CA et al (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3–25
Lipinski C, Hopkins A (2004) Navigating chemical space for biology and medicine. Nature 432:855–861
Frye SV (2010) The art of the chemical probe. Nat Chem Biol 6(3):159–161
Murray AJ (2008) Pharmacological PKA inhibition: all may not be what it seems. Sci Signal 1:re4
Cohen P (2010) Guidelines for the effective use of chemical inhibitors of protein function to understand their roles in cell regulation. Biochem J 425:53–54
Lipinski CA (2010) Overview of hit to lead: the medicinal chemist’s role from HTS retest to lead optimization hand off. In: Hayward MM (ed) Lead-seeking approaches: topics in medicinal chemistry, 5th edn. Springer, Berlin, pp 125–140
Wagner BK, Clemons PA (2009) Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling. Curr Opin Chem Biol 13:539–548
Rishton GM (2003) Nonleadlikeness and leadlikeness in biochemical screening. Drug Discov Today 8:86–96
Singh J et al (2011) The resurgence of covalent drugs. Nat Rev Drug Discov 10:307–317
Heal WP, Dang THT, Tate EW (2011) Activity-based probes: discovering new biology and new drug targets. Chem Soc Rev 40:246–257
Gleeson MP et al (2011) Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat Rev Drug Discov 10:197–208
Matson SL et al (2009) Best practices in compound management for preserving compound integrity and accurately providing samples for assays. J Biomol Screen 14:476–484
McDonald GR et al (2008) Bioactive contaminants leach from disposable laboratory plasticware. Science 322:917
Hermann JC et al (2013) Metal impurities cause false positives in high-throughput screening campaigns. ACS Med Chem Lett 4:197–200
Thorne N, Auld DS, Inglese J (2010) Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol 14:315–324
Thorne N et al (2012) Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Chem Biol 19:1060–1072
Schenone M et al (2013) Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol 9:232–240
Williams HD et al (2012) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65:315–499
Meanwell NA (2011) Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem 54:2529–2591
Böhm H-J et al (2004) Fluorine in medicinal chemistry. ChemBioChem 5:637–643
Sun H, Tawa G, Wallqvist A (2012) Classification of scaffold-hopping approaches. Drug Discov Today 17:310–324
Heretsch P, Tzagkaroulaki L, Giannis A (2010) Modulators of the hedgehog signaling pathway. Bioorg Med Chem 18:6613–6624
Heretsch P, Tzagkaroulaki L, Giannis A (2010) Cyclopamine and hedgehog signaling: chemistry, biology, medical perspectives. Angew Chem Int Ed 49:3418–3427
Chen JK et al (2002) Small molecule modulation of smoothened activity. Proc Natl Acad Sci 99:14071–14076
Robarge KD et al (2009) GDC-0449—a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 19:5576–5581
Yauch RL et al (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326:572–574
Wu X et al (2002) A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am Chem Soc 124:14520–14521
Sinha S, Chen JK (2005) Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol 2:29–30
Stanton BZ et al (2009) A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol 5:154–156
Hyman JM et al (2009) Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 106:14132–14137
Firestone AJ et al (2012) Small-molecule inhibitors of the AAA+ ATPase motor cytoplasmic dynein. Nature 484:125–129
Acknowledgements
We thank Gary Sulikowski for his helpful guidance and input. J.E.H. is supported by an American Heart Association Postdoctoral Fellowship (14POST19550002). C.C.H. is supported by the US NIH NHLBI (1R01HL104040), the US Veterans Administration (101BX000771), and the Cali Family Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hempel, J.E., Hong, C.C. (2015). Practical Strategies for Small-Molecule Probe Development in Chemical Biology. In: Hempel, J., Williams, C., Hong, C. (eds) Chemical Biology. Methods in Molecular Biology, vol 1263. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2269-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2269-7_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2268-0
Online ISBN: 978-1-4939-2269-7
eBook Packages: Springer Protocols